CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-06-15 | Sallin Aymeric Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2018-06-15 | SPRINGER TIMOTHY A Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2018-06-15 | ZENNER PATRICK J Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2018-05-30 | Farokhzad Omid Director | Grant or award · Stock Option (Right to Buy) | +95,000 | 95,000 | ||
| 2017-11-17 | Sands Earl Chief Medical Officer | Purchase | +7,500 | $10.26 | $77K | 7,500 |
| 2017-11-17 | Leaman John Harold CFO, Treas. & Hd Corp Strategy | Grant or award · Stock Option (right to buy) | +220,000 | 220,000 | ||
| 2017-11-17 | Smolinski Stephen Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +80,000 | 80,000 | ||
| 2017-11-14 | SPRINGER TIMOTHY A Director | Purchase | +57,598 | $9.27 | $534K | 461,349 |
| 2017-11-14 | Abraham David GC, CCO & Corporate Secretary | Purchase | +5,405 | $9.25 | $50K | 5,405 |
| 2017-11-13 | CAUTREELS WERNER President and CEO | Purchase | +20,000 | $9.31 | $186K | 321,203 |
| 2017-11-10 | SPRINGER TIMOTHY A Director | Purchase | +4,752 | $9.03 | $43K | 9,752 |
Page 32 of 32 · 631 trades